Biological
20-valent pneumococcal conjugate vaccine (20vPnC)
20-valent pneumococcal conjugate vaccine (20vPnC) is a biological therapy with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
2
40%
Ph phase_3
2
40%
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Active, not recruiting2
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 32 (40.0%)
Trials by Status
active_not_recruiting240%
completed240%
not_yet_recruiting120%
Recent Activity
2 active trials
Showing 5 of 5
not_yet_recruitingphase_3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
NCT07573462
active_not_recruitingphase_2
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
NCT06524414
completedphase_2
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
NCT06531538
active_not_recruitingphase_1
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
NCT06182124
completedphase_3
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2
NCT04887948
Clinical Trials (5)
Showing 5 of 5 trials
NCT07573462Phase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
NCT06524414Phase 2
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
NCT06531538Phase 2
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
NCT06182124Phase 1
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
NCT04887948Phase 3
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5